Fresenius Kabi
Clinical trials sponsored by Fresenius Kabi, explained in plain language.
-
New study checks if IV fat emulsion prevents nutrient shortages in Long-Term patients
Disease control Recruiting nowThis study looks at how safe SMOFlipid is for children and adults who need IV nutrition for 8 weeks or more. It checks if the treatment causes a lack of essential fats or liver problems. About 100 participants will be followed to see how their bodies respond.
Phase: PHASE4 • Sponsor: Fresenius Kabi • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Fish oil treatment tested for kids with liver damage from IV nutrition
Disease control Recruiting nowThis study is testing the safety of Omegaven, a fish oil-based fat emulsion, in 40 children under 18 who have developed liver problems (cholestasis) from long-term IV nutrition. The main goal is to see how many children develop essential fatty acid deficiency during at least 8 we…
Sponsor: Fresenius Kabi • Aim: Disease control
Last updated Jun 26, 2026 13:42 UTC